We also discovered that CD38 expression positively correlated with PD-1, CTLA-4, TIGHIT, GITR, LAG-3, and VISTA, indicating that upregulated CD38 levels in tumor microenvironment mediated ICI-resistance. The gene discussed is CD38; the disease is neoplasm.